Fieldview Capital Management LLC Purchases Shares of 7,936 Align Technology, Inc. $ALGN

Fieldview Capital Management LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,936 shares of the medical equipment provider’s stock, valued at approximately $994,000.

Other institutional investors also recently modified their holdings of the company. Sentry Investment Management LLC raised its position in Align Technology by 73.1% during the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 79 shares during the last quarter. Steigerwald Gordon & Koch Inc. acquired a new position in Align Technology during the 3rd quarter worth about $26,000. Rothschild Investment LLC grew its position in shares of Align Technology by 140.3% in the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 87 shares during the last quarter. Quent Capital LLC bought a new stake in shares of Align Technology in the 3rd quarter valued at about $30,000. Finally, TD Private Client Wealth LLC increased its stake in shares of Align Technology by 135.6% in the third quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 137 shares during the period. Institutional investors own 88.43% of the company’s stock.

Align Technology Trading Up 0.6%

ALGN stock opened at $175.09 on Tuesday. The firm has a market cap of $12.48 billion, a PE ratio of 30.93, a price-to-earnings-growth ratio of 1.90 and a beta of 1.79. The stock has a 50-day moving average price of $174.98 and a 200-day moving average price of $152.65. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $208.30.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, beating the consensus estimate of $2.99 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.44 EPS. On average, analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Insider Activity

In other Align Technology news, EVP John Morici sold 7,969 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total transaction of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares in the company, valued at approximately $1,559,346.47. This represents a 49.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Wells Fargo & Company lifted their price objective on Align Technology from $181.00 to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Stifel Nicolaus increased their target price on shares of Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Mizuho raised their price target on shares of Align Technology from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Leerink Partners boosted their price target on shares of Align Technology from $210.00 to $225.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 16th. Six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Align Technology currently has a consensus rating of “Hold” and an average price target of $198.08.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.